SCHEMBL9705874

SCHEMBL9705874

CC1CC(=O)C=C2CC[C@@H]3[C@@H](CC[C@@]4(C)[C@H]3CCC4(C)O)[C@]21C

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SHBG P04278 7/20 0.66
NR3C1 P04150 3/20 0.66
ALDH1A1 P00352 2/20 0.66
PGR P06401 2/20 0.66
ADRA1A P35348 1/20 0.66
HTR2B P41595 1/20 0.66
LMNA P02545 4/20 0.58
MAPT P10636 2/20 0.58
CYP2C19 P33261 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
SERPINA6 P08185 3/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
BLM P54132 2/20 0.49
ADORA3 P0DMS8 1/20 0.49
MAPK3 P27361 1/20 0.49
SLC6A3 Q01959 1/20 0.49
TSHR P16473 2/20 0.48
HIF1A Q16665 2/20 0.48
AR P10275 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9705867 1.00 SHBG (0.66) SHBGNR3C1ALDH1A1PGRADRA1A
SCHEMBL3029696 0.87 LMNA (0.67) SHBGNR3C1ALDH1A1PGRADRA1A
SCHEMBL11660767 0.86 SHBG (0.61) SHBGNR3C1ALDH1A1PGRADRA1A
SCHEMBL11660763 0.86 SHBG (0.61) SHBGNR3C1ALDH1A1PGRADRA1A
SCHEMBL10745748 0.85 SHBG (0.49) SHBGNR3C1ALDH1A1PGRADRA1A
SCHEMBL10745742 0.85 SHBG (0.49) SHBGNR3C1ALDH1A1PGRADRA1A
SCHEMBL11440167 0.85 SHBG (0.60) SHBGNR3C1ALDH1A1PGRADRA1A
SCHEMBL11427618 0.85 SHBG (0.60) SHBGNR3C1ALDH1A1PGRADRA1A
SCHEMBL11427622 0.85 SHBG (0.60) SHBGNR3C1ALDH1A1PGRADRA1A
SCHEMBL9643566 0.84 SHBG (0.48) SHBGNR3C1ALDH1A1PGRADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0218647-B1 SKIN TREATMENT AGENTS SCHERING AKTIENGESELLSCHAFT (DE) 1992-06-17 EP disclosed
US-4859659-A ACNE TREATMENT SCHERING AKTIENGESELLSCHAFT (DE) 1989-08-22 US disclosed
US-4673673-A ANTIANDROGENS SCHERING AKTIENGESELLSCHAFT (DE) 1987-06-16 US disclosed
EP-0062903-A1 17-Alpha-alkyl-17-beta-hydroxy-1-alpha-methyl-4-androsten-3-ones, process for their preparation and pharmaceutical compositions containing them SCHERING AKTIENGESELLSCHAFT (DE) 1982-10-20 EP disclosed